^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    FS120

    i
    Other names: FS120, FS 120, FS-120
    Associations

    News

    Trials
    Company:
    Sino Biopharm
    Drug class:
    CD137 agonist, OX40 agonist
    Related drugs:
    Associations

    News

    Trials
    over3years
    [VIRTUAL] A first-in-human phase I study of FS120, an OX40/CD137 tetravalent bispecific antibody, in patients with advanced malignancies (ESMO 2021)
    Exploratory translational endpoints will also be included in the study. Study enrolment began December 2020.
    Clinical • P1 data • IO biomarker
    |
    TNFRSF9 (TNF Receptor Superfamily Member 9)
    |
    FS120